Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

Douglas R. Adkins, Jin Ching Lin, Assuntina Sacco, Jessica Ley, Peter Oppelt, Vyacheslay Vanchenko, Nataliia Komashko, Chia Jui Yen, Trisha Wise-Draper, Jose Lopez-Picazo Gonzalez, Sinisa Radulovic, Qi Shen, Holger Thurm, Jean François Martini, Justin Hoffman, Xin Huang, Bohuslav Melichar, Makoto Tahara

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences